This website is using cookies to provide a good browsing experience. These include essential cookies that are necessary for the operation of the site, as well as others that are used for anonymous statistical purposes.

This website is using cookies to provide a good browsing experience. These include essential cookies that are necessary for the operation of the site, as well as others that are used for anonymous statistical purposes.

Your cookie preferences have been saved.
Press Release - March 28, 2023

After many years of research and development, ATANIS Biotech AG was incorporated as a spinoff of the University of Bern in June 2021. The four co-founders Noemi Zbären, Jean-Pierre Kinet, Thomas Kaufmann and Alexander Eggel bring >70 years of combined experience in basic and clinical allergy research, cell and molecular biology and diagnostic assay development to the company and have published >250 publications in peer-reviewed high-impact journals.

Our team

Mrs. Noemi Bachmeier-Zbären

Co-founder, Managing Director & CTO

ATANIS Biotech – Mrs. Noemi Bachmeier-Zbären – Co-founder, Managing Director & CTO

Prof. Dr. Jean-Pierre Kinet

Co-Founder & CEO

ATANIS Biotech – Prof. Dr. Jean-Pierre Kinet – Co-Founder & CEO

Mrs. Doris Corpataux

Regulatory Affairs Manager

ATANIS Biotech – Mrs. Doris Corpataux – Regulatory Affairs Manager

Mr. Nathan Laborde

Quality Assurance Manager

ATANIS Biotech – Mr. Nathan Laborde – Quality Assurance Manager

Mrs. Charlène Niogret

Clinical Affairs Manager

ATANIS Biotech – Mrs. Charlène Niogret – Clinical Affairs Manager

Mrs. Antonia Ferreira

Research Assistant

ATANIS Biotech – Mrs. Antonia Ferreira – Research Assistant

Mrs. Robin van Brummelen

Research Assistant

ATANIS Biotech – Mrs. Robin van Brummelen – Research Assistant

Mrs. Marianne Zwicker

Laboratory Manager

ATANIS Biotech – Mrs. Marianne Zwicker – Laboratory Manager

Mrs. Sophie Buchser

Research Assistant

ATANIS Biotech – Mrs. Sophie Buchser – Research Assistant

Prof. Dr. Thomas Kaufmann

Co-Founder & Scientific Advisor

ATANIS Biotech – Prof. Dr. Thomas Kaufmann – Co-Founder & Scientific Advisor

Prof. Dr. Alexander Eggel

Co-Founder & Scientific Advisor

ATANIS Biotech – Prof. Dr. Alexander Eggel – Co-Founder & Scientific Advisor

Our Customers

Our customer base reaches from highly established industrial partners to individual research groups.

IgGenix

IgGenix is a biotechnology company, directly address food and other severe allergies by re-engineering key antibodies involved in the allergic cascade.

Mabylon

Mabylon AG is a Swiss biotechnology company harnessing the therapeutic potential of naturally occurring human antibodies to treat allergies and neurodegenerative diseases.

CSL Behring

CSL Behring is a leading global biotech company driven by its promise to save and improve lives.

Excellergy

Excellergy is a biotechnology company developing new therapeutic modalities in various diseases.

KGK Science

KGK Science provides high-quality clinical research trials and expert regulatory support for the nutraceutical industries.

Octapharma AG

Octapharma is one of the largest human protein product manufacturers.

Our Investors

Are you interested to invest in ATANIS Biotech AG or to financially support us? Please get in touch!